TY  - GEN
AU  - Liao,Yulin
AU  - Asakura,Masanori
AU  - Takashima,Seiji
AU  - Ogai,Akiko
AU  - Asano,Yoshihiro
AU  - Shintani,Yasunori
AU  - Minamino,Tetsuo
AU  - Asanuma,Hiroshi
AU  - Sanada,Shoji
AU  - Kim,Jiyoong
AU  - Kitamura,Soichiro
AU  - Tomoike,Hitonobu
AU  - Hori,Masatsugu
AU  - Kitakaze,Masafumi
TI  - Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice
SN  - 1524-4539
PY  - 2005///0208
KW  - Adrenergic beta-1 Receptor Antagonists
KW  - Adrenergic beta-Antagonists
KW  - pharmacology
KW  - Animals
KW  - Cardiomegaly
KW  - etiology
KW  - Celiprolol
KW  - Cells, Cultured
KW  - drug effects
KW  - Disease Progression
KW  - Drug Evaluation, Preclinical
KW  - Enzyme Induction
KW  - Fibrosis
KW  - Gene Expression Regulation
KW  - Heart Failure
KW  - Hypertrophy
KW  - Isoproterenol
KW  - Male
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Myocardium
KW  - pathology
KW  - Myocytes, Cardiac
KW  - NG-Nitroarginine Methyl Ester
KW  - Natriuretic Peptide, Brain
KW  - biosynthesis
KW  - Nitric Oxide
KW  - physiology
KW  - Nitric Oxide Synthase
KW  - genetics
KW  - Nitric Oxide Synthase Type II
KW  - Nitric Oxide Synthase Type III
KW  - Phenylephrine
KW  - Pressure
KW  - adverse effects
KW  - RNA, Messenger
KW  - Rats
KW  - Transcription, Genetic
KW  - Vasodilator Agents
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1161/01.CIR.0000137831.08683.E1
ER  -